Articles by Annika Kim Constantino
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company's closely watched experimental weight loss pill, orforglipοΏ½...
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.
The future of the booming obesity drug market won't hinge on drugs that deliver greater weight loss alone.Β
...
President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec. 19, 2025.
Drug pricing. Looming patent cliffs. Dealmaking.Β The first year of Trump 2.0...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
Good morninοΏ½...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
Next week, οΏ½...
The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment acceοΏ½...
UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in threοΏ½...
Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company's injection Zepbound and NoοΏ½...
Health and Human Services Secretary Robert F. Kennedy Jr.'s hand-picked vaccine committee is scheduled to vote Thursday on whether to change a longstanding recommendation that every baby get vaccinatοΏ½...
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the cοΏ½...
